Reginster JY - Search Results

1

Recommendations for the registration of agents used in the prevention and treatment of glucocorticoid-induced osteoporosis.

Compston JE, Audran M, Avouac B, Bouvenot G, Devogelaer J, Eastell R, Fabris F, Gennari C, Jones EA, Kaufman JM, Lemmel E, Mazzuoli G, Reid DM, Ringe JD, Vanhaelst L, Ziegler R, Reginster JY. Compston JE, et al. Among authors: reginster jy. Calcif Tissue Int. 1996 Nov;59(5):323-7. doi: 10.1007/s002239900134. Calcif Tissue Int. 1996. PMID: 8849396 No abstract available.

2

Recommendations for the registration of drugs intended for use in the treatment of male osteoporosis.

Kaufman JM, Compston J, Audran MA, Avouac B, Devogelaer JP, Lemmel EM, Vanhaelst L, Reginster JY. Kaufman JM, et al. Among authors: reginster jy. Calcif Tissue Int. 1999 Jul;65(1):4-7. doi: 10.1007/s002239900649. Calcif Tissue Int. 1999. PMID: 10369725 Review. No abstract available.

3

Recommendations for the registration of new chemical entities used in the prevention and treatment of osteoporosis.

Reginster JY, Compston JE, Jones EA, Kaufman JM, Audran M, Bouvenot G, Frati L, Mazzuoli G, Gennari C, Lemmel EM, et al. Reginster JY, et al. Calcif Tissue Int. 1995 Oct;57(4):247-50. doi: 10.1007/BF00298877. Calcif Tissue Int. 1995. PMID: 8673859 No abstract available.

4

Recommendations for the health economics analysis to be performed with a drug to be registered in prevention or treatment of osteoporosis.

Dere W, Avouac B, Boers M, Buxton M, Christiansen C, Dawson A, Gennari C, Guillemin F, Lawaetz H, Ornskov F, Roumagnac I, Reginster JY. Dere W, et al. Among authors: reginster jy. Calcif Tissue Int. 1998 Aug;63(2):93-7. doi: 10.1007/BF03322783. Calcif Tissue Int. 1998. PMID: 9685510 Review. No abstract available.

5

Do estrogens effectively prevent osteoporosis-related fractures? The Group for the Respect of Ethics and Excellence in Science.

Reginster JY, Bruyere O, Audran M, Avouac B, Body JJ, Bouvenot G, Brandi ML, Gennari C, Kaufman JM, Lemmel EM, Vanhaelst L, Weryha G, Devogelaer JP. Reginster JY, et al. Calcif Tissue Int. 2000 Sep;67(3):191-4. doi: 10.1007/s002230001135. Calcif Tissue Int. 2000. PMID: 10954771 Free article. Review. No abstract available.

6

Design for an ipriflavone multicenter European fracture study.

Reginster JY, Bufalino L, Christiansen C, Devogelaer JP, Gennari C, Riis BJ, Roux C. Reginster JY, et al. Calcif Tissue Int. 1997;61 Suppl 1:S28-32. doi: 10.1007/s002239900382. Calcif Tissue Int. 1997. PMID: 9263614 Clinical Trial.

7

Bisphosphonates and osteoporosis treatment in Italy.

Gennari C, Reginster JY. Gennari C, et al. Among authors: reginster jy. Aging (Milano). 1998 Aug;10(4):284-94. doi: 10.1007/BF03339790. Aging (Milano). 1998. PMID: 9825019 Review.

8

Management of glucocorticoid-induced osteoporosis.

Rizzoli R, Adachi JD, Cooper C, Dere W, Devogelaer JP, Diez-Perez A, Kanis JA, Laslop A, Mitlak B, Papapoulos S, Ralston S, Reiter S, Werhya G, Reginster JY. Rizzoli R, et al. Among authors: reginster jy. Calcif Tissue Int. 2012 Oct;91(4):225-43. doi: 10.1007/s00223-012-9630-5. Epub 2012 Aug 10. Calcif Tissue Int. 2012. PMID: 22878667 Review.

9

[Treatment of postmenopausal osteoporosis in 2004].

Reginster JY, Devogelaer JP. Reginster JY, et al. Rev Med Liege. 2004 Nov;59(11):633-47. Rev Med Liege. 2004. PMID: 15646737 Free article. Review. French.

10

[Postmenopausal osteoporosis in women].

Reginster JY, Devogelaer JP, Kaufman JM, Appelboom T, Vanhaelst L. Reginster JY, et al. Rev Med Liege. 1999 Apr;54(4):335-40. Rev Med Liege. 1999. PMID: 10389480 Free article. French.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

989 results

Search Page

Filters